Bracken, A.P. and Pasini, D. and Capra, M. and Prosperini, E. and Colli, E. and Helin, K., Correction to: EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer (The EMBO Journal, (2003), 22, 20, (5323-5335), 10.1093/emboj/cdg542), EMBO Journal, 43, (5), 2024, p886 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Glancy E, Wang C, Tuck E, Healy E, Amato S, Neikes HK, Mariani A, Mucha M, Vermeulen M, Pasini D, Bracken AP, PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1, MOLECULAR CELL, 2023,
Journal Article,
PUBLISHED
|
Bracken, A.P. and Kleine-Kohlbrecher, D. and Dietrich, N. and Pasini, D. and Gargiulo, G. and Beekman, C. and Theilgaard-Mönch, K. and Minucci, S. and Porse, B.T. and Marine, J.-C. and Hansen, K.H. and Helin, K., Corrigendum: The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, Genes & development, 37, (17-18), 2023, p861 ,
Notes: [cited By 0],
Journal Article,
PUBLISHED
DOI
|
Brien GL, Bressan RB, Monger C, Gannon D, Lagan E, Doherty AM, Healy E, Neikes H, Fitzpatrick DJ, Deevy O, Grant V, Marqués-Torrejón MA, Alfazema N, Pollard SM, Bracken AP., Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells., Nature Genetics, 53, (8), 2021, p1221 - 1232,
Journal Article,
PUBLISHED
TARA - Full Text
|
Glancy, E. and Ciferri, C. and Bracken, A.P., Structural basis for PRC2 engagement with chromatin, Current Opinion in Structural Biology, 67, 2020, p135-144 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Lanigan F, Gallagher WM and Bracken AP., 'A method of predicting risk of recurrence of cancer', TCD and UCD, US 10,557,175, 2020, Jointly owned by TCD and UCD,
Notes: [The invention relates to a method of predicting the risk of tumour recurrence in a subject. Specifically, the invention relates to a method of predicting the risk of early-stage node -negative breast cancer, prostate cancer and other tumour recurrence],
Patent,
GRANTED
URL
|
Healy E, Mucha M, Glancy E, Fitzpatrick DJ, Conway E, Neikes HK, Monger C, Van Mierlo G, Baltissen MP, Koseki Y, Vermeulen M, Koseki H, and Bracken AP. , PRC2.1 and PRC2.2 synergize to co-ordinate H3K27 tri-methylation, Molecular Cell, 2019, p437-452.e6 ,
Journal Article,
PUBLISHED
DOI
|
Deevy O and Bracken AP., PRC2 functions in development and congenital disorders, Development, 146, (19), 2019, pdev181354 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Bracken AP, Brien GL and Verrijzer CP., Dangerous Liaisons: Interplay between SWI/SNF, NuRD and Polycomb in Chromatin Regulation and Cancer. , Genes & Development, 33, 2019, p1 - 24,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Lanigan F, Gallagher WM and Bracken AP., 'A method of predicting risk of recurrence of cancer,', TCD and UCD, EP3194621, 2019, Jointly owned by TCD and UCD,
Notes: [The invention relates to a method of predicting the risk of tumour recurrence in a subject. Specifically, the invention relates to a method of predicting the risk of early-stage node -negative breast cancer, prostate cancer and other tumour recurrence],
Patent,
GRANTED
URL
|
|